8 articles in this category
Therapeutic innovation often measures success in quarters or product life cycles. But what if we shifted the horizon to seven generations—roughly 140 ...
Introduction: The Seven-Generation Challenge in TherapeuticsThe concept of seven-generation thinking, rooted in Indigenous governance, asks us to cons...
The most celebrated breakthroughs in therapeutic innovation often arrive with fanfare: a new drug approval, a novel device launch, a headline-grabbing...
Therapeutic development is a marathon, not a sprint—yet most project plans treat it like a series of short dashes. Teams race to hit preclinical miles...
Every few months, a new therapeutic app or device promises to revolutionize mental health care. Many launch with splashy press releases and impressive...
Therapeutic innovation often promises transformation, yet many promising starts fade into irrelevance or cause unintended harm. This guide is for team...
The Broken Harvest: My Experience with the Monoculture ModelIn my career, I've managed Phase III trials across three continents, and the pattern is di...
Every novel therapy carries a hidden cost. Before a single patient receives a dose of a gene-edited cell therapy or an mRNA vaccine, resources have be...